136 related articles for article (PubMed ID: 38367662)
21. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers.
Joshi S; Lewis SJ; Creanor S; Ayling RM
Ann Clin Biochem; 2010 May; 47(Pt 3):259-63. PubMed ID: 19740914
[TBL] [Abstract][Full Text] [Related]
22. Fecal calprotectin concentrations in healthy children aged 1-18 months.
Li F; Ma J; Geng S; Wang J; Liu J; Zhang J; Sheng X
PLoS One; 2015; 10(3):e0119574. PubMed ID: 25742018
[TBL] [Abstract][Full Text] [Related]
23. High faecal calprotectin levels in healthy, exclusively breast-fed infants.
Savino F; Castagno E; Calabrese R; Viola S; Oggero R; Miniero R
Neonatology; 2010 Jun; 97(4):299-304. PubMed ID: 19887860
[TBL] [Abstract][Full Text] [Related]
24. Possible Adverse Effects of Food Additive E171 (Titanium Dioxide) Related to Particle Specific Human Toxicity, Including the Immune System.
Bischoff NS; de Kok TM; Sijm DTHM; van Breda SG; Briedé JJ; Castenmiller JJM; Opperhuizen A; Chirino YI; Dirven H; Gott D; Houdeau E; Oomen AG; Poulsen M; Rogler G; van Loveren H
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379217
[TBL] [Abstract][Full Text] [Related]
25. Impact of food grade and nano-TiO
Dudefoi W; Moniz K; Allen-Vercoe E; Ropers MH; Walker VK
Food Chem Toxicol; 2017 Aug; 106(Pt A):242-249. PubMed ID: 28564612
[TBL] [Abstract][Full Text] [Related]
26. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings.
Hradsky O; Ohem J; Mitrova K; Durilova M; Kotalova R; Nevoral J; Kolho KL; Bronsky J
Clin Lab; 2014; 60(12):1993-2000. PubMed ID: 25651733
[TBL] [Abstract][Full Text] [Related]
27. The search for gastrointestinal inflammation in autism: a systematic review and meta-analysis of non-invasive gastrointestinal markers.
Mathew NE; McCaffrey D; Walker AK; Mallitt KA; Masi A; Morris MJ; Ooi CY
Mol Autism; 2024 Jan; 15(1):4. PubMed ID: 38233886
[TBL] [Abstract][Full Text] [Related]
28. Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma.
Lehmann FS; Trapani F; Fueglistaler I; Terracciano LM; von Flüe M; Cathomas G; Zettl A; Benkert P; Oertli D; Beglinger C
World J Gastroenterol; 2014 May; 20(17):4994-9. PubMed ID: 24803811
[TBL] [Abstract][Full Text] [Related]
29. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.
Chen CC; Huang JL; Chang CJ; Kong MS
J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):541-7. PubMed ID: 22699836
[TBL] [Abstract][Full Text] [Related]
30. Consecutive Monitoring of Fecal Calprotectin and Lactoferrin for the Early Diagnosis and Prediction of Pouchitis after Restorative Proctocolectomy for Ulcerative Colitis.
Yamamoto T; Shimoyama T; Bamba T; Matsumoto K
Am J Gastroenterol; 2015 Jun; 110(6):881-7. PubMed ID: 25916224
[TBL] [Abstract][Full Text] [Related]
31. Ingestion of titanium dioxide nanoparticles: a definite health risk for consumers and their progeny.
Cornu R; Béduneau A; Martin H
Arch Toxicol; 2022 Oct; 96(10):2655-2686. PubMed ID: 35895099
[TBL] [Abstract][Full Text] [Related]
32. Jejunal villus absorption and paracellular tight junction permeability are major routes for early intestinal uptake of food-grade TiO
Coméra C; Cartier C; Gaultier E; Catrice O; Panouille Q; El Hamdi S; Tirez K; Nelissen I; Théodorou V; Houdeau E
Part Fibre Toxicol; 2020 Jun; 17(1):26. PubMed ID: 32527323
[TBL] [Abstract][Full Text] [Related]
33. Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome.
Campbell JP; Zierold C; Rode AM; Blocki FA; Vaughn BP
J Clin Gastroenterol; 2021 Mar; 55(3):239-243. PubMed ID: 32324678
[TBL] [Abstract][Full Text] [Related]
34. Infant Feeding, Gut Permeability, and Gut Inflammation Markers.
Koivusaari K; Niinistö S; Nevalainen J; Honkanen J; Ruohtula T; Koreasalo M; Ahonen S; Åkerlund M; Tapanainen H; Siljander H; Miettinen ME; Alatossava T; Ilonen J; Vaarala O; Knip M; Virtanen SM
J Pediatr Gastroenterol Nutr; 2023 Jun; 76(6):822-829. PubMed ID: 36913717
[TBL] [Abstract][Full Text] [Related]
35. Impact of the Food Additive Titanium Dioxide (E171) on Gut Microbiota-Host Interaction.
Pinget G; Tan J; Janac B; Kaakoush NO; Angelatos AS; O'Sullivan J; Koay YC; Sierro F; Davis J; Divakarla SK; Khanal D; Moore RJ; Stanley D; Chrzanowski W; Macia L
Front Nutr; 2019; 6():57. PubMed ID: 31165072
[TBL] [Abstract][Full Text] [Related]
36. Alleviative Effect of Lactoferrin Interventions Against the Hepatotoxicity Induced by Titanium Dioxide Nanoparticles.
Zhang W; Sun J; Liu F; Li S; Wang X; Su L; Liu G
Biol Trace Elem Res; 2024 Feb; 202(2):624-642. PubMed ID: 37191759
[TBL] [Abstract][Full Text] [Related]
37. Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
Heida A; Knol M; Kobold AM; Bootsman J; Dijkstra G; van Rheenen PF
Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1742-1749.e2. PubMed ID: 28606846
[TBL] [Abstract][Full Text] [Related]
38. A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy.
Bar-Gil Shitrit A; Koslowsky B; Livovsky DM; Shitrit D; Paz K; Adar T; Adler SN; Goldin E
Scand J Gastroenterol; 2017 Mar; 52(3):328-333. PubMed ID: 27841040
[TBL] [Abstract][Full Text] [Related]
39. Effects of oral exposure to titanium dioxide nanoparticles on gut microbiota and gut-associated metabolism in vivo.
Chen Z; Han S; Zhou D; Zhou S; Jia G
Nanoscale; 2019 Nov; 11(46):22398-22412. PubMed ID: 31738363
[TBL] [Abstract][Full Text] [Related]
40. Fecal biomarkers of environmental enteric dysfunction and associated factors among children aged 24-59 months in east Dembiya district, northwest Ethiopia.
Gizaw Z; Yalew AW; Bitew BD; Lee J; Bisesi M
BMC Gastroenterol; 2022 Apr; 22(1):172. PubMed ID: 35395735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
